Two Seas Capital »

Indivior Pharmaceuticals shares owned by Two Seas Capital

Quarter-by-quarter ownership of Indivior Pharmaceuticals (INDV) shares owned by Two Seas Capital from 13F filings

Historical chart of Two Seas Capital investment in Indivior Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Indivior Pharmaceuticals held by Two Seas Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Indivior Pharmaceuticals by Two Seas Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $145M 4.7M 30.48

More positions owned by Two Seas Capital

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Core Scientific (CORZ)
Roivant Sciences SHS (ROIV)
Spdr Series Trust State Street Spd Put Option (XBI)
Apple Put Option (AAPL)
Calumet (CLMT)
Talen Energy Corp (TLN)
First Solar (FSLR)
Indivior Pharmaceuticals (INDV)
Nektar Therapeutics Com New (NKTR)
Gannett (TDAY)
Sable Offshore Corp Com Shs (SOC)
Echostar Corp Cl A (SATS)
Sotera Health (SHC)
Arbutus Biopharma (ABUS)

View all positions for Two Seas Capital

Top funds holding Indivior Pharmaceuticals

BlackRock
Vanguard Portfolio Management
Oaktree Capital Management
Madison Avenue Partners
Vanguard Capital Management
Two Seas Capital
Millennium Management
Citadel Advisors
Morgan Stanley
Deerfield Management Company
Geode Capital Management
Goldman Sachs Group
UBS Group
Driehaus Capital Management
Newtyn Management

View all funds holding Indivior Pharmaceuticals